CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 84 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q4 2018. The put-call ratio across all filers is 3.04 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $40,000 | +90.5% | 20,523 | +20.6% | 0.00% | – |
| Q4 2020 | $21,000 | -47.5% | 17,018 | -23.8% | 0.00% | – |
| Q3 2020 | $40,000 | -76.9% | 22,321 | +8.4% | 0.00% | -100.0% |
| Q2 2020 | $173,000 | +158.2% | 20,590 | +62.2% | 0.00% | – |
| Q1 2020 | $67,000 | -44.2% | 12,696 | -42.4% | 0.00% | -100.0% |
| Q4 2019 | $120,000 | +1.7% | 22,031 | -9.2% | 0.00% | 0.0% |
| Q3 2019 | $118,000 | -31.0% | 24,264 | -1.4% | 0.00% | 0.0% |
| Q2 2019 | $171,000 | -9.5% | 24,617 | -9.6% | 0.00% | 0.0% |
| Q1 2019 | $189,000 | +31.2% | 27,226 | +10.4% | 0.00% | 0.0% |
| Q4 2018 | $144,000 | -35.1% | 24,655 | -16.2% | 0.00% | -50.0% |
| Q3 2018 | $222,000 | +44.2% | 29,431 | -3.8% | 0.00% | +100.0% |
| Q2 2018 | $154,000 | -21.0% | 30,585 | -4.4% | 0.00% | 0.0% |
| Q1 2018 | $195,000 | -25.3% | 31,986 | -13.0% | 0.00% | -50.0% |
| Q4 2017 | $261,000 | – | 36,756 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,563,925 | $16,717,000 | 29.31% |
| Cormorant Asset Management, LP | 2,000,000 | $13,580,000 | 1.50% |
| Perceptive Advisors | 2,701,023 | $18,339,000 | 1.18% |
| Fosun International Ltd | 700,071 | $4,753,000 | 0.53% |
| Ghost Tree Capital, LLC | 200,000 | $1,358,000 | 0.22% |
| ACUTA CAPITAL PARTNERS, LLC | 81,302 | $552,000 | 0.21% |
| IFP Advisors, Inc | 300,000 | $2,037,000 | 0.11% |
| CONNING INC. | 351,280 | $2,385,000 | 0.10% |
| WOODSTOCK CORP | 39,931 | $271,000 | 0.06% |
| Yellowstone Partners, LLC | 15,944 | $108,000 | 0.04% |